Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-05-20
1987-09-15
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505
Patent
active
046940073
ABSTRACT:
A method of treating infections of Toxoplasmosis or P. carini comprising administering to the host an effective amount of trimetrexate, (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline.
REFERENCES:
patent: 4376858 (1983-03-01), Colbry
patent: 4391809 (1983-07-01), Elslager
The Merck Index, 9th Ed., Merck & Co., Inc., Rahway, N.J., 1976, p. 544, No. 4086.
Allegra Carmen
Chabner Bruce A.
Drake James C.
Kovacs Joseph A.
Masur Henry
Goldberg Jerome D.
The United States of America as represented by the Secretary of
LandOfFree
Use of trimetrexate as antiparasitic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of trimetrexate as antiparasitic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of trimetrexate as antiparasitic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385180